Natalie Gukasyan, M.D., medical director, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore.
The treatment of depression has improved dramatically over the last half-century. The introduction of selective serotonin reuptake inhibitors (SSRIs) in…
Read More >
